Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP920573.RAIl2J4SFiO-_2lG6RiTfRYinEppFDLCY56l-D_Su_MXE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP920573.RAIl2J4SFiO-_2lG6RiTfRYinEppFDLCY56l-D_Su_MXE130_assertion type Assertion NP920573.RAIl2J4SFiO-_2lG6RiTfRYinEppFDLCY56l-D_Su_MXE130_head.
- NP920573.RAIl2J4SFiO-_2lG6RiTfRYinEppFDLCY56l-D_Su_MXE130_assertion description "[To understand how SKI promotes tumor growth we used gain- and loss-of-function approaches and found that simultaneously to blocking the TGF-beta-growth inhibitory pathway, SKI promotes the switch of Smad3 from tumor suppression to oncogenesis by favoring phosphorylations of the Smad3 linker region in melanoma cells but not in normal human melanocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP920573.RAIl2J4SFiO-_2lG6RiTfRYinEppFDLCY56l-D_Su_MXE130_provenance.
- NP920573.RAIl2J4SFiO-_2lG6RiTfRYinEppFDLCY56l-D_Su_MXE130_assertion evidence source_evidence_literature NP920573.RAIl2J4SFiO-_2lG6RiTfRYinEppFDLCY56l-D_Su_MXE130_provenance.
- NP920573.RAIl2J4SFiO-_2lG6RiTfRYinEppFDLCY56l-D_Su_MXE130_assertion SIO_000772 19845874 NP920573.RAIl2J4SFiO-_2lG6RiTfRYinEppFDLCY56l-D_Su_MXE130_provenance.
- NP920573.RAIl2J4SFiO-_2lG6RiTfRYinEppFDLCY56l-D_Su_MXE130_assertion wasDerivedFrom befree-20150227 NP920573.RAIl2J4SFiO-_2lG6RiTfRYinEppFDLCY56l-D_Su_MXE130_provenance.
- NP920573.RAIl2J4SFiO-_2lG6RiTfRYinEppFDLCY56l-D_Su_MXE130_assertion wasGeneratedBy ECO_0000203 NP920573.RAIl2J4SFiO-_2lG6RiTfRYinEppFDLCY56l-D_Su_MXE130_provenance.